Previous 10 | Next 10 |
Summary Two years ago, in the best article I've ever written, I identified 10 investment bubbles that would likely produce poor long-term returns. But I also pointed out that hiding in cash was not the best alternative. So, I shared over 11 individual investments that I thought woul...
Summary Davis Selected Advisers 13F portfolio value increased from $14.06B to $14.71B this quarter. They increased Meta Platforms, Amazon.com, and Markel while reducing Cigna, JD.com, and Coupang. The top three positions are Berkshire Hathaway, Wells Fargo, and Capital One Financial...
Quest Diagnostics and NewYork-Presbyterian Agree to Laboratory Services Transaction PR Newswire Goal to serve NewYork-Presbyterian's providers and patients in the greater New York region and beyond SECAUCUS, N.J. and NEW YORK , Feb. 14, 2023 /...
Summary I've been covering Quest Diagnostics for some time. While it can be argued that the company has beaten estimates, it's also clear that positive catalysts are few. I've been neutral going on for a year now at this time, and I see no reason to change my tune going into early 2023....
Quest Diagnostics to Host Investor Day on March 16, 2023 PR Newswire SECAUCUS, N.J. , Feb. 13, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will host an Investor Day for institutional...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The Dividend Champions list is a m...
Quest Diagnostics Incorporated (DGX) Q4 2022 Earnings Conference Call February 2, 2023 8:30 am ET Company Participants Jim Davis - President, Chief Executive Officer Sam Samad - Executive Vice President, Chief Financial Officer Shawn Bevec - Vice President, Investor Re...
Despite reporting better than expected Q4 2022 financials, Quest Diagnostics ( NYSE: DGX ) shed ~2% in the morning hours Thursday as the company set its 2023 revenue outlook below consensus amid falling revenue linked to COVID-19 testing. "COVID-19 testing revenues declined as...
Quest Diagnostics press release ( NYSE: DGX ): Q4 Non-GAAP EPS of $1.98 beats by $0.08 . Revenue of $2.33B (-15.0% Y/Y) beats by $70M . FY2023 reported diluted EPS expected to be between $7.61 and $8.21; and adjusted diluted EPS expected to be between $8.40 and $9.00 v...
QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2023 PR Newswire Fourth quarter revenues of $2.33 billion , down 15.0% from 2021 Fourth quarter reported diluted earnings per share ("EPS") of $0.87 , dow...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
NORTHAMPTON, MA / ACCESSWIRE / July 30, 2024 / Bread of Life Academy, a program under nonprofit Bread of Life Inc. -a Quest for Health Equity (Q4HE) grantee-recently held a graduation ceremony to celebrate a graduating class of 40 students pursuing careers as phlebotomists and community health ...
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer PR Newswire BALTIMORE, Md. and MONTREAL , July 29, 2024 /PRN...
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...